AdjAssocProf Craig Haifer

AdjAssocProf Craig Haifer

Conjoint Associate Professor

2010

Bachelor of Medicine/Bachelor of Surgery (Honours) – Monash University

2017

Fellow of the RACP - Gastroenterology and Hepatology

2022

Doctorate of Philosophy – The University of Sydney

Medicine & Health
School of Clinical Medicine

Assocaite Professor Craig Haifer is a Staff Specialist in the Gastroenterology Department at St Vincent’s Hospital in Sydney and a Conjoint Associate Professor at the School of Clinical Medicine, University of New South Wales. He works clinically in the private and public sector with subspecialty expertise in the mangement of Inflammatory Bowel Disease (Crohn's disease and ulcerative colitis) along with microibal manipulation with FMT.

In addition to his clinical work, he has active research interests in the role of gut microbiome in the development of gastrointestinal and systemic diseases. Dr Haifer completed his PhD through Sydney University assessing the role of faecal microbiota transplantation to treat and further explore the pathogenesis of GI diseases. He has continued his academic pursuits with UNSW and is actively supervising both Honours and PhD students whilst expanding his FMT based research in non-GI diseases including the field of oncology and haematology whilst pursuing ways to use the data derived from FMT to develop next generation microbial based therapies.

As an early career researcher, he has received over $2million of research funding through organisations including the Gastroenterological Society of Australia, NSW Health, The St Vincent’s Clinic Foundation and the Cancer Research Institue and has collaborations within the university and associated clinical schools as well as national and international research institutes and biotechnology companies. He has a track record of successful projects with first author publications in high-ranking gastroenterology journals including Lancet: Gastroenterology and Hepatology and Gut.  

  • Journal articles | 2025
    Sin HCL; Haifer C, 2025, 'Faecal transplantation: the good, the bad and the ugly', Internal Medicine Journal, 55, pp. 35 - 40, http://dx.doi.org/10.1111/imj.16559
    Journal articles | 2024
    Chen-Liaw A; Aggarwala V; Mogno I; Haifer C; Li Z; Eggers J; Helmus D; Hart A; Wehkamp J; Lamousé-Smith ESN; Kerby RL; Rey FE; Colombel JF; Kamm MA; Olle B; Norman JM; Menon R; Watson AR; Crossett E; Terveer EM; Keller JJ; Borody TJ; Grinspan A; Paramsothy S; Kaakoush NO; Dubinsky MC; Faith JJ, 2024, 'Gut microbiota strain richness is species specific and affects engraftment', Nature, http://dx.doi.org/10.1038/s41586-024-08242-x
    Journal articles | 2024
    Chetwood JD; Paramsothy S; Haifer C; Borody TJ; Kamm MA; Leong RW; Kaakoush NO, 2024, 'Key metabolomic alterations are associated with ulcerative colitis disease state and activity: A validation analysis', Gut, 73, pp. 1392 - 1393, http://dx.doi.org/10.1136/gutjnl-2023-330196
    Journal articles | 2024
    Majzoub ME; Luu LDW; Haifer C; Paramsothy S; Borody TJ; Leong RW; Thomas T; Kaakoush NO, 2024, 'Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling', mSystems, 9, http://dx.doi.org/10.1128/msystems.00746-24
    Journal articles | 2024
    Majzoub ME; Paramsothy S; Haifer C; Parthasarathy R; Borody TJ; Leong RW; Kamm MA; Kaakoush NO, 2024, 'The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-53454-4
    Journal articles | 2024
    Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Lan-San Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2024, 'Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial', Clinical Gastroenterology and Hepatology, 22, pp. 2299 - 2308.e5, http://dx.doi.org/10.1016/j.cgh.2024.04.019
    Journal articles | 2023
    Haifer C; Luu LDW; Paramsothy S; Borody TJ; Leong RW; Kaakoush NO, 2023, 'Microbial determinants of effective donors in faecal microbiota transplantation for UC', Gut, 72, pp. 90 - 100, http://dx.doi.org/10.1136/gutjnl-2022-327742
    Journal articles | 2022
    Haifer C; Paramsothy S; Kaakoush NO; Leong RW, 2022, 'Oral faecal microbiota transplantation in ulcerative colitis – Authors' reply', The Lancet Gastroenterology and Hepatology, 7, pp. 286 - 287, http://dx.doi.org/10.1016/S2468-1253(22)00045-0
    Journal articles | 2022
    Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW, 2022, 'Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial', The Lancet Gastroenterology and Hepatology, 7, pp. 141 - 151, http://dx.doi.org/10.1016/S2468-1253(21)00400-3
    Journal articles | 2021
    Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO, 2021, 'Long-term bacterial and fungal dynamics following oral lyophilized fecal microbiota transplantation in clostridioides difficile infection', mSystems, 6, http://dx.doi.org/10.1128/MSYSTEMS.00905-20
    Journal articles | 2021
    Haifer C; Saikal A; Paramsothy R; Kaakoush NO; Leong RW; Borody TJ; Kamm MA; Paramsothy S, 2021, 'Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy', GUT, 70, pp. 2210 - 2210, http://dx.doi.org/10.1136/gutjnl-2020-323581
    Journal articles | 2021
    Haifer C; Saikal A; Paramsothy R; Kaakoush NO; Leong RW; Borody TJ; Kamm MA; Paramsothy S, 2021, 'Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy', Gut, 70, pp. 2210 - 2211, http://dx.doi.org/10.1136/gutjnl-2020-323581
    Journal articles | 2021
    Haifer C; Srinivasan A; An YK; Picardo S; van Langenberg D; Menon S; Begun J; Ghaly S; Thin L, 2021, 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study', Medical Journal of Australia, 214, pp. 128 - 133, http://dx.doi.org/10.5694/mja2.50824
    Journal articles | 2021
    Srinivasan A; Haifer C; Thin L, 2021, 'Editorial: outcomes following a second switch—evaluating clinical outcomes and patient perspectives in IBD', Alimentary Pharmacology and Therapeutics, 53, pp. 1038 - 1039, http://dx.doi.org/10.1111/apt.16325
    Journal articles | 2021
    Srinivasan A; Haifer C; Thin L, 2021, 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab', Medical Journal of Australia, 215, pp. 435, http://dx.doi.org/10.5694/mja2.51303
    Journal articles | 2020
    Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PDR; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice', Gut, 69, pp. 801 - 810, http://dx.doi.org/10.1136/gutjnl-2019-320260
    Journal articles | 2020
    Haifer C; Leong RW; Paramsothy S, 2020, 'The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease', Current Opinion in Pharmacology, 55, pp. 8 - 16, http://dx.doi.org/10.1016/j.coph.2020.08.009
    Journal articles | 2019
    Haifer C; Lawrance IC; Center JR; Clarke MW; Hart PH; Eisman JA; Lucas R; Ghaly S, 2019, 'Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission', Therapeutic Advances in Gastroenterology, 12, http://dx.doi.org/10.1177/1756284819865144
    Journal articles | 2019
    Pudipeddi A; Kariyawasam V; Haifer C; Baraty B; Paramsothy S; Leong RWL, 2019, 'Safety of drugs used for the treatment of Crohn’s disease', Expert Opinion on Drug Safety, 18, pp. 357 - 367, http://dx.doi.org/10.1080/14740338.2019.1612874
    Journal articles | 2018
    Chan W; Lynch N; Bampton P; Chang J; Chung A; Florin T; Hetzel DJ; Jakobovits S; Moore G; Pavli P; Radford-Smith G; Thin L; Baraty B; Haifer C; Yau Y; Leong RWL, 2018, 'Entyvio lengthen dose-interval study: Lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease', European Journal of Gastroenterology and Hepatology, 30, pp. 735 - 740, http://dx.doi.org/10.1097/MEG.0000000000001150
    Journal articles | 2018
    Chan W; Shim HH; Ng SC; Liu J; Inglis C; Greveson K; Baraty B; Haifer C; Leong RWL, 2018, 'A global survey of gastroenterologists' travel advice to patients with inflammatory bowel disease on immunosuppressive agents and management of those visiting tuberculosis-endemic areas', Journal of Crohn's and Colitis, 12, pp. 1261 - 1269, http://dx.doi.org/10.1093/ecco-jcc/jjy110
    Journal articles | 2018
    Sood S; Haifer C; Yu L; Pavlovic J; Gow PJ; Jones RM; Visvanathan K; Angus PW; Testro AG, 2018, 'Early viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation', Transplant Infectious Disease, 20, http://dx.doi.org/10.1111/tid.12934
    Journal articles | 2017
    Sood S; Haifer C; Yu L; Pavlovic J; Churilov L; Gow PJ; Jones RM; Angus PW; Visvanathan K; Testro AG, 2017, 'A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation', Liver Transplantation, 23, pp. 487 - 497, http://dx.doi.org/10.1002/lt.24730
    Journal articles | 2015
    Sood S; Haifer C; Yu L; Pavlovic J; Gow PJ; Jones RM; Visvanathan K; Angus PW; Testro AG, 2015, 'Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation', Liver Transplantation, 21, pp. 1478 - 1485, http://dx.doi.org/10.1002/lt.24216
  • Conference Abstracts | 2024
    Cameron K; Sam M; Thennakoon N; Gu B; Arzivian A; Skinner T; Shelton E; Haifer C; Connor SJ; Toong C; Gibson P; Gibson D; Boussioutas A; Sparrow MP; Ward M, 2024, 'The role of bound anti-drug antibodies to infliximab in predicting future immunogenic failure when de-escalating from combination therapy with an immunomodulator to anti-TNF monotherapy: The Risk Assessment of drug-bound anti-drug-antibodies for Predicting immunogenicity during Immunomodulator De-escalation to Infliximab Monotherapy (RAPIDIM) Study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 211 - 212
    Conference Abstracts | 2024
    Giddings H; Ng K-S; Solomon M; Arzivian A; Haifer C; Lin H; Pappas C; Clark D; Deacon A; Radford-Smith G; Ebrahimi N; Wu A; Lewis M; Lim R; Zhang J; Vasudevan A; Demase K; Karp J; Fernandes R; An Y-K; Ng ZQ; Mackenzie S; Thin L; Greeve T; Moore G; Ghaly S, 2024, 'Post operative recurrence and surgical outcomes following Crohn's ileocolic resections in Australia (PORSCIA study)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 248 - 249
    Conference Abstracts | 2024
    Sam M; Cameron K; Ward M; Rexhepi T; Gu B; Haifer C; Connor SJ; Harman D; Donald W; Toong C, 2024, 'Comparison of drug tolerant assays for the measurement of bound anti-infliximab antibodies in patient serum', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 150 - 150
    Conference Abstracts | 2024
    Seng C; Su WK; Wilson W; Haifer C; Williams A-J; Forbes A; Lawrance I; Lynch K; Brett L; Begun J; Connor SJ; Andrews J; Walker G, 2024, 'A cross section of inflammatory bowel disease management in older persons in Australasia: Crohn's Colitis Cure (CCC) data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 188 - 189
    Conference Abstracts | 2024
    Sin HCL; Baraty B; Li V; Ghaly S; Haifer C, 2024, 'Intestinal ultrasound in immune checkpoint inhibitor-related colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 214 - 215
    Conference Abstracts | 2024
    Su WK; Wilson W; Pipicella J; Haifer C; Williams A-J; Lynch K; Forbes A; Walker G; Schultz M; Lawrance I; An Y-K; Brett L; Connor SJ; Andrews J, 2024, 'The real-world use of five aminosalicylate treatment for ulcerative colitis: Crohn's Colitis Cure (CCC) data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 181 - 182
    Conference Abstracts | 2024
    Tamilarasan AG; Yang X; Haifer C; Section SP; Leong R, 2024, 'Development and validation of a convolutional neural network model in the detection of Crohn's disease erosions and ulcers by pan-enteric wireless capsule endoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 195 - 196
    Conference Papers | 2023
    Chetwood J; Paramsothy S; Haifer C; Leong R; Kaakoush NO, 2023, 'Key metabolomic alterations are associated with ulcerative colitis disease state and activity', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 108 - 109
    Conference Papers | 2023
    Fernandes R; Gilmore R; Ruddick-Collins L; Rice K; Gazelakis K; Moore G; Vasudevan A; Zhang J; Wright E; Schildkraut T; Clark N; Schultz M; Brownson A; Haifer C; Bracken LML; Mahy G; Swe E; Lynch K; Ngoi B; Judge C; Kim DH; Kim HS; Lee HS; Kim KO; Lee YJ; Kim S-J; Lee J; Song EM; Park SH; Kim DJ; Sagami S; Kobayashi T; Jing L; Cao Q; Wei S-C; Lin W-C; Lin C-C; Hsu W-G; Mak J; Begun J; Kim ES; An Y-K, 2023, 'Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 190 - 192
    Conference Papers | 2023
    Fernandes R; Gilmore R; Ruddick-Collins L; Rice K; Moore G; Gazelakis K; Vasudevan A; Zhang J; Wright E; Schildkraut T; Clark N; Schultz M; Brownson A; Haifer C; Bracken LML; Mahy G; Swe E; Judge C; Ngoi B; Lynch K; Begun J; An Y-K, 2023, 'Cessation of corticosteroids after acute severe ulcerative colitis may be associated with increased colectomy risk: Results of the ANZ-ASUC study in collaboration with the ANZIBDC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 186 - 187
    Conference Papers | 2023
    Mcnamara J; Ghaly S; Pipicella J; Wilson W; Goodfellow T; Cheema M; Lynch K; Williams A; Begun J; Gearry R; Kim A; Haifer C; Forbes A; Lawrence I; Schultz M; Walker G; Radford-Smith G; Andrews J; Connor S, 2023, 'Variation of outcomes in inflammatory bowel disease at 10 Australian and New Zealand centers: Crohn's Colitis Cure data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 168 - 169
    Conference Papers | 2023
    Mcnamara J; Wilson W; Pipicella J; Goodfellow T; Haifer C; Gearry R; Forbes A; Williams A; Lynch K; Lawrence I; Schultz M; Walker G; Radford-Smith G; Brett L; Verdon C; Lores T; Connor S; Andrews J, 2023, 'Burden of mental health issues in people with inflammatory bowel disease in Australasia: Crohn's Colitis Cure data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 165 - 165
    Conference Papers | 2023
    Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Leong R, 2023, 'Withdrawal vs continuation of thiopurine in vedolizumab-treated patients with ulcerative colitis (VIEWS): A multicenter randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 123 - 124
    Conference Abstracts | 2023
    Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2023
    Suo P; Thin L; Srinivasan A; An Y-K; Fernandes R; Ghaly S; Jeffrey A; Menon S; Winston J; Haifer C, 2023, 'Comparing long-term outcomes in patients with inflammatory bowel disease between switch and non-switch cohorts: No differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 170 - 170
    Conference Abstracts | 2023
    Suo P; Thin L; Srinivasan A; Winston J; Jeffrey A; Menon S; Ghaly S; Haifer C, 2023, 'Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 884 - 884, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2023
    Tamilarasan AG; Yang J; Haifer C; Baraty B; Bestawros D; Paramsothy S; Leong R, 2023, 'Comparison of diagnostic modalities for Crohn's disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 153 - 154
    Preprints | 2022
    Chen-Liaw A; Aggarwala V; Mogno I; Haifer C; Li Z; Eggers J; Helmus D; Hart A; Wehkamp J; Lamousé-Smith ESN; Kerby RL; Rey FE; Colombel JF; Kamm MA; Borody TJ; Grinspan A; Paramsothy S; Kaakoush NO; Dubinsky MC; Faith JJ, 2022, Gut microbiota bacterial strain richness is species specific and limits therapeutic engraftment, http://dx.doi.org/10.1101/2022.11.01.514782
    Conference Abstracts | 2022
    Leong R; Haifer C; Kaakoush N; Chetwood J; Pudipeddi A; Paramsothy S, 2022, 'Baseline endoscopic activity and concomitant medications in the prediction of oral fecal microbiota therapeutic efficacy in mild-moderate ulcerative colitis: Lyophilised Oral Faecal Microbiota Transplantation for Ulcerative Colitis (LOTUS) study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 170 - 171, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Pudipeddi A; Fung C; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y; Begun J; Connor S; Chetwood J; Paramsothy S; Leong R, 2022, 'HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A149 - A150, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.207
    Conference Papers | 2022
    Pudipeddi A; Fung C; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y; Begun J; Connor S; Chetwood J; Paramsothy S; Leong R, 2022, 'Histological remission using a Nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 170 - 170, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2022
    Tamilarasan AG; Yang X; Zhou L; Haifer C; Katelaris P; Paramsothy S; Leong R, 2022, 'Development and validation of a convolutional neural network model in the detection of Crohn's disease erosions and ulcers by panenteric wireless capsule endoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 173 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2021
    Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong RW, 2021, 'LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) - RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, Vol. 160, pp. S135 - S135, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Haifer C, 2021, 'Catastrophe prevention: Acute severe ulcerative colitis', in Journal of Gastroenterology and Hepatology (Australia), pp. 34, http://dx.doi.org/10.1111/jgh.15459
    Conference Abstracts | 2020
    Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong RW, 2020, 'Lyophilised Oral Faecal Microbiota Transplantation in the Management of Ulcerative Colitis (LOTUS Study): Results from the induction phase of a randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 116 - 117, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Haifer C; Srinivasan A; Menon S; An Y; Picardo S; Van Langenberg D; Begun J; Ghaly S; Thin L, 2019, 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 155 - 156, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100242&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Haifer C; Lucas RM; Clarke MW; Lawrance I; Hart PH; Center JR; Eisman JA; Ghaly S, 2018, 'Vitamin D deficiency in Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S152 - S153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318900247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1